A novel method of calculating stroke volume using point-of-care echocardiography.

Background: Point-of-care transthoracic echocardiography (POC-TTE) is essential in shock management, allowing for stroke volume (SV) and cardiac output (CO) estimation using left ventricular outflow tract diameter (LVOTD) and left ventricular velocity time integral (VTI). Since LVOTD is difficult to obtain and error-prone, the body surface area (BSA) or a modified BSA (mBSA) is sometimes used as a surrogate (LVOTD, LVOTD). Currently, no models of LVOTD based on patient characteristics exist nor have BSA-based alternatives been validated.

Methods: Focused rapid echocardiographic evaluations (FREEs) performed in intensive care unit patients over a 3-year period were reviewed. The age, sex, height, and weight were recorded. Human expert measurement of LVOTD (LVOTD) was performed. An epsilon-support vector regression was used to derive a computer model of the predicted LVOTD (LVOTD). Training, testing, and validation were completed. Pearson coefficient and Bland-Altman were used to assess correlation and agreement.

Results: Two hundred eighty-seven TTEs with ideal images of the LVOT were identified. LVOTD was the best method of SV measurement, with a correlation of 0.87. LVOTD and LVOTD had correlations of 0.71 and 0.49 respectively. Root mean square error for LVOTD, LVOTD, and LVOTD respectively were 13.3, 37.0, and 26.4. Bland-Altman for LVOTD demonstrated a bias of 5.2. LVOTD model was used in a separate validation set of 116 ideal images yielding a linear correlation of 0.83 between SV and SV. Bland Altman analysis for SV had a bias of 2.3 with limits of agreement (LOAs) of - 24 and 29, a percent error (PE) of 34% and a root mean square error (RMSE) of 13.9.

Conclusions: A computer model may allow for SV and CO measurement when the LVOTD cannot be assessed. Further study is needed to assess the accuracy of the model in various patient populations and in comparison to the gold standard pulmonary artery catheter. The LVOTD is more accurate with less error compared to BSA-based methods, however there is still a percentage error of 33%. BSA should not be used as a surrogate measure of LVOTD. Once validated and improved this model may improve feasibility and allow hemodynamic monitoring via POC-TTE once it is validated.